NEUROCRINE BIOSCIENCES INC (NBIX)       101.22  +2.01 (+2.03%)

101.22  +2.01 (+2.03%)

US64125C1099 - Common Stock - After market: 101.22 0 (0%)

Buy % Consensus

78
Analysts have set a mean price target of 128.74. This target is 27.19% above the current price.
NBIX was analyzed by 34 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about NBIX.
In the previous month the buy percentage consensus was at a similar level.
NBIX was analyzed by 34 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target

Price Low Median Mean High 101.2293.93132.60128.74157.50 - -7.20% 31.00% 27.19% 55.60%

Up and Down Grades

Date Firm Action Rating
2023-03-30 Canaccord Genuity Upgrade Hold -> Buy
2023-03-03 Evercore ISI Group Upgrade In-Line -> Outperform
2023-02-07 Cantor Fitzgerald Reiterate Overweight
2023-02-07 Mizuho Maintains Neutral
2023-02-07 RBC Capital Maintains Sector Perform
2023-02-07 Barclays Maintains Overweight
2023-02-07 Wedbush Maintains Outperform
2023-02-07 Wells Fargo Maintains Equal-Weight
2023-02-07 Piper Sandler Maintains Neutral
2023-02-07 Citigroup Maintains Buy
2023-02-07 HC Wainwright & Co. Reiterate Buy
2023-02-03 Morgan Stanley Upgrade Equal-Weight -> Overweight
2022-11-14 Evercore ISI Group Downgrade Outperform -> In-Line
2022-11-03 Raymond James Maintains Outperform
2022-11-03 JP Morgan Maintains Overweight
2022-11-02 Cantor Fitzgerald Maintains Overweight
2022-11-02 Mizuho Maintains Neutral
2022-11-02 RBC Capital Maintains Sector Perform
2022-11-02 SVB Leerink Maintains Market Perform
2022-11-02 Wells Fargo Maintains Equal-Weight
2022-11-02 Morgan Stanley Maintains Equal-Weight
2022-11-02 Piper Sandler Maintains Neutral
2022-10-24 Citigroup Maintains Buy
2022-10-20 Mizuho Maintains Neutral
2022-10-11 UBS Initiate Buy
2022-09-26 Wells Fargo Initiate Equal-Weight
2022-08-08 Mizuho Maintains Neutral
2022-08-05 Barclays Maintains Overweight
2022-07-15 Morgan Stanley Maintains Equal-Weight
2022-04-12 Barclays Maintains Overweight

Analyst Ratings Stock Screener Links

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA